135 related articles for article (PubMed ID: 19395202)
1. Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis.
Dandekar P; Harmer C; Barbachano Y; Rhys-Evans P; Harrington K; Nutting C; Newbold K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):518-21. PubMed ID: 19395202
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.
De Crevoisier R; Baudin E; Bachelot A; Leboulleux S; Travagli JP; Caillou B; Schlumberger M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1137-43. PubMed ID: 15519785
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
Heron DE; Karimpour S; Grigsby PW
Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
[TBL] [Abstract][Full Text] [Related]
6. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
[TBL] [Abstract][Full Text] [Related]
7. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.
Chen J; Tward JD; Shrieve DC; Hitchcock YJ
Am J Clin Oncol; 2008 Oct; 31(5):460-4. PubMed ID: 18838882
[TBL] [Abstract][Full Text] [Related]
8. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
[TBL] [Abstract][Full Text] [Related]
9. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
Vrbic S; Pejcic I; Vrbic M; Filipovic S
J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
Junor EJ; Paul J; Reed NS
Eur J Surg Oncol; 1992 Apr; 18(2):83-8. PubMed ID: 1582515
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective analysis of anaplastic thyroid carcinoma].
Zhang ZM; Xu ZG; Tang PZ; Xue LY; Lü N
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):322-4. PubMed ID: 16900624
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.
Swaak-Kragten AT; de Wilt JH; Schmitz PI; Bontenbal M; Levendag PC
Radiother Oncol; 2009 Jul; 92(1):100-4. PubMed ID: 19328572
[TBL] [Abstract][Full Text] [Related]
15. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma.
Mitchell G; Huddart R; Harmer C
Radiother Oncol; 1999 Jan; 50(1):33-8. PubMed ID: 10225555
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic cancer, lymphoma, and metastases of the thyroid gland.
Pasieka JL
Surg Oncol Clin N Am; 1998 Oct; 7(4):707-20. PubMed ID: 9735130
[TBL] [Abstract][Full Text] [Related]
18. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group.
Tennvall J; Lundell G; Hallquist A; Wahlberg P; Wallin G; Tibblin S
Cancer; 1994 Aug; 74(4):1348-54. PubMed ID: 8055459
[TBL] [Abstract][Full Text] [Related]
19. [Transcutaneous radiotherapy after thyroidectomy for differentiated thyroid carcinoma].
Busutti L; Blotta AB; Calò-Gabrieli G; dell'Erba L
Clin Ter; 1999; 150(2):103-7. PubMed ID: 10396858
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
